125 related articles for article (PubMed ID: 3341058)
21. [Hepatitis in hemophiliacs with multiple transfusions].
Filová A; Hrubisková K; Hrubisko M; Malícková D; Nováková J; Pokorná G
Vnitr Lek; 1982 Mar; 28(3):230-6. PubMed ID: 7112967
[No Abstract] [Full Text] [Related]
22. [Infection caused by the human immunodeficiency virus, hepatitis B virus and delta virus in homosexual males].
Bassa A; Villalonga C; Parras F; Salvà F; Altés J; Salas A
Med Clin (Barc); 1989 Oct; 93(13):490-2. PubMed ID: 2622241
[TBL] [Abstract][Full Text] [Related]
23. Transfusion and cytomegalovirus-associated AIDS-defining disease in hemophiliacs. Hemophilia Malignancy Study.
Ragni MV; Triulzi DJ; Bass D; Duerstein S
Transfusion; 1996 Aug; 36(8):681-4. PubMed ID: 8780661
[TBL] [Abstract][Full Text] [Related]
24. Estimate of the risk of post transfusion hepatitis B in Jakarta, Indonesia.
Mboi N; Olson JG; McGreevy PB; Tan R; Moeslichan S
Int J Epidemiol; 1981 Dec; 10(4):367-72. PubMed ID: 7327835
[TBL] [Abstract][Full Text] [Related]
25. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
[TBL] [Abstract][Full Text] [Related]
26. [Epidemiology of hepatitis in Swiss hemophiliacs].
Bütler R; Stampfli K
Schweiz Med Wochenschr; 1979 Oct; 109(39):1449-53. PubMed ID: 556269
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1.
Jackson JB; Erice A; Englund JA; Edson JR; Balfour HH
Transfusion; 1988; 28(2):187-9. PubMed ID: 2895517
[TBL] [Abstract][Full Text] [Related]
28. The prevalence and interaction of human immunodeficiency virus and hepatitis B virus infections in Israeli hemophiliacs.
Brenner B; Schwartz S; Ben-Porath E; Tatarsky I; Varon D; Martinowitz U
Isr J Med Sci; 1991 Oct; 27(10):557-61. PubMed ID: 1955309
[TBL] [Abstract][Full Text] [Related]
29. Transmission of hepatitis B and hepatitis delta viruses in the households of chronic hepatitis B surface antigen carriers: a regression analysis of indicators of risk.
Craxì A; Tinè F; Vinci M; Almasio P; Cammà C; Garofalo G; Pagliaro L
Am J Epidemiol; 1991 Sep; 134(6):641-50. PubMed ID: 1951268
[TBL] [Abstract][Full Text] [Related]
30. B and delta hepatitis virus infection in a population of west Africa.
Zanchetta N; Vigano P; Ferrario MP; Priuli GB; Djigbenoude O; Nardi GP; Pagano A
Rev Inst Med Trop Sao Paulo; 1990; 32(1):36-40. PubMed ID: 2259830
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of AIDS in hemophiliacs in Japan.
Abe T; Kazama M; Kinoshita T; Matuda J; Yoshimura Y; Ryu T; Takahashi I
Semin Thromb Hemost; 1985 Oct; 11(4):352-6. PubMed ID: 4071060
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and clinical implications of occult hepatitis B viral infection in hemophilia patients in Japan.
Toyoda H; Hayashi K; Murakami Y; Honda T; Katano Y; Nakano I; Goto H; Kumada T; Takamatsu J
J Med Virol; 2004 Jun; 73(2):195-9. PubMed ID: 15122792
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular enzyme patterns and hepatitis B virus exposure in multitransfused young and very young hemophilia patients.
Gomperts ED; Lazerson J; Berg D; Lockhart D; Sergis-Deavenport E
Am J Hematol; 1981; 11(1):55-9. PubMed ID: 6791495
[TBL] [Abstract][Full Text] [Related]
34. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
Perrillo RP; Chau KH; Overby LR; Decker RH
Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
[TBL] [Abstract][Full Text] [Related]
35. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs.
Mannucci PM; Zanetti AR; Gringeri A; Tanzi E; Morfini M; Messori A; Tirindelli MC; de Biasi R; Ciavarella N; Colombo M
Arch Intern Med; 1989 Jun; 149(6):1333-7. PubMed ID: 2525013
[TBL] [Abstract][Full Text] [Related]
36. Sero-surveillance of transmissible hepatitis B & C viruses in asymptomatic HIV infection in haemophilics.
Sengupta B; De M; Lahiri P; Bhattacharya DK
Indian J Med Res; 1992 Nov; 95():256-8. PubMed ID: 1283980
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of type B and non-A, non-B hepatitis in hemophilia: relationship to chronic liver disease.
Kim HC; Saidi P; Ackley AM; Bringelsen KA; Gocke DJ
Gastroenterology; 1980 Dec; 79(6):1159-64. PubMed ID: 6777232
[TBL] [Abstract][Full Text] [Related]
38. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
Abe T
AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
[TBL] [Abstract][Full Text] [Related]
39. Progression to acquired immunodeficiency syndrome in 94 human immunodeficiency virus-positive hemophiliacs with long-term follow-up.
Lorenzo JI; Moscardó F; López-Aldeguer J; Aznar JA
Haematologica; 2001 Mar; 86(3):291-6. PubMed ID: 11357820
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive.
Novick DM; Farci P; Croxson TS; Taylor MB; Schneebaum CW; Lai ME; Bach N; Senie RT; Gelb AM; Kreek MJ
J Infect Dis; 1988 Oct; 158(4):795-803. PubMed ID: 3171227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
